With US FDA Adcomm Meetings Disappearing, Sponsors Seek Other Outlets For Patient Voice

 
• By Derrick Gingery
  
FDA advisory committee meetings, including their open public hearings, have become a rare occurrence in 2025. (Screenshot of FDA Broadcast)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US Advisory Committees

More from United States